Nonmelanoma Skin Cancer Mortality in the United States, 1969 Through 1988

doi:10.1001/archderm.1993.01680310056009

You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Vol. 129 No. 10, October 1993

Online Only
	•	Online First Table of Contents

Studies

•	Online Features

This Article
•	References
•	Full text PDF
•	Reply to article
•	Send to a friend
•	Save in My Folder
•	Save to citation manager
•	Permissions

Citing Articles
•	Citation map
•	Citing articles on HighWire
•	Citing articles on Web of Science (56)
•	Contact me when this article is cited

Related Content
•	Similar articles in this journal

Social Bookmarking
	What's this?

Nonmelanoma Skin Cancer Mortality in the United States, 1969 Through 1988

Martin A. Weinstock, MD, PhD

Arch Dermatol. 1993;129(10):1286-1290.

Abstract

Background and Design
Nonmelanoma skin cancer is the most common malignancy in theUnited States. Despite its importance, patterns of mortalityfrom this cause are poorly documented. Recent insights intosources of misclassification allow for more accurate estimationof these patterns. This investigation describes nonmelanomaskin cancer mortality in the United States during 1969 through1988 on the basis of routine death certification and adjustsreported mortality data for two major sources of misclassification.

Results
Nonmelanoma skin cancer mortality rates decreased by approximately20% to 30% for both men and women and for both whites and blacks,although the decline among blacks was less consistent than amongwhites. Mortality was greater among men than among women andgreater among whites than among blacks, although the most pronounceddifference was between white men and the other three racial/gender groups studied. Approximately 1200 deaths per year areattributable to nonmelanoma skin cancer.

Conclusions
Nonmelanoma skin cancer mortality is diminishing despite increasingincidence. Mortality rates among blacks are extraordinarilyhigh in comparison with their incidence rates. More carefulattention to misclassification in mortality statistics is crucialfor an accurate assessment of the public health burden of nonmelanomaskin cancer.

(Arch Dermatol. 1993;129:1286-1290)

Author Affiliations

From the Dermatoepidemiology Unit, Veterans Affairs and Roger Williams Medical Centers and Brown University, Providence, RI.

Add to CiteULike CiteULike Add to Connotea Connotea Add to Delicious Delicious Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Economic Impact of Non-Melanoma Skin Cancer: A Review
Mudigonda et al.
J Natl Compr Canc Netw 2010;8:888-896.
ABSTRACT | FULL TEXT

Association Between Statin Use and Risk for Keratinocyte Carcinoma in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
Dore et al.
ANN INTERN MED 2009;150:9-18.
ABSTRACT | FULL TEXT

Association of ACE Inhibitors and Angiotensin Receptor Blockers with Keratinocyte Cancer Prevention in the Randomized VATTC Trial
Christian et al.
JNCI J Natl Cancer Inst 2008;100:1223-1232.
ABSTRACT | FULL TEXT

Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia
O'Shaughnessy et al.
Clin. Cancer Res. 2002;8:314-346.
ABSTRACT | FULL TEXT

Risk of Developing a Subsequent Nonmelanoma Skin Cancer in Patients With a History of Nonmelanoma Skin Cancer: A Critical Review of the Literature and Meta-analysis
Marcil and Stern
Arch Dermatol 2000;136:1524-1530.
ABSTRACT | FULL TEXT

Death From Skin Cancer Among the Elderly: Epidemiological Patterns
Weinstock
Arch Dermatol 1997;133:1207-1209.
ABSTRACT

Primary Care Clinicians' Performance for Detecting Actinic Keratoses and Skin Cancer
Whited et al.
Arch Intern Med 1997;157:985-990.
ABSTRACT

Socioeconomic Status and Attitudes of 51 Patients With Giant Basal and Squamous Cell Carcinoma and Paired Controls
Robinson et al.
Arch Dermatol 1995;131:428-431.
ABSTRACT

| | |